FOREST LABORATORIES v. SIGMAPHARM LABORATORIES

2017-2369, 2017-2370, 2017-2372, 2017-2373, 2017-2374, 2017-2375, 2017-2376, 2017-2389, 2017-2412, 2017-2436, 2017-2438, 2017-2440, 2017-2441.

918 F.3d 928 (2019)

FOREST LABORATORIES, LLC, fka Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Plaintiffs-Cross-Appellants v. SIGMAPHARM LABORATORIES, LLC, Defendant-Appellee Hikma Pharmaceuticals LLC, Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc., fka West-Ward Pharmaceuticals Corp., Breckenridge Pharmaceutical Inc., Alembic Pharmaceuticals Ltd., Alembic Global Holding S.A., Alembic Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals Co. India Pvt. Ltd., Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

Decided: March 14, 2019.


Attorney(s) appearing for the Case

Howard Warren Levine , Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for plaintiffs-cross-appellants. Also represented by Jonathan Robert Davies , Sanya Sukduang ; Charles E. Lipsey , Reston, VA.

Anthony R. Friedman , The Simon Law Firm, P.C., St. Louis, MO, argued for defendant-appellee. Also represented by Anthony G. Simon .

Clifford Katz , Kelley Drye & Warren, LLP, New York, NY, argued for all defendants-appellants. Defendant-appellant Breckenridge Pharmaceutical Inc. also represented by Malavika Rao .

Imron T. Aly , Schiff Hardin LLP, Chicago, IL, for defendants-appellants Hikma Pharmaceuticals LLC, Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc. Also represented by Joel M. Wallace .

Ksenia Takhistova , Hunton Andrews Kurth LLP, New York, NY, for defendants-appellants Alembic Pharmaceuticals Ltd., Alembic Global Holding S.A., Alembic Pharmaceuticals Inc.

Michael R. Dzwonczyk , Sughrue Mion PLLC, Washington, DC, for defendants-appellants Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Amneal Pharmaceuticals Co. India Pvt. Ltd.

Before Prost, Chief Judge, Dyk and Moore, Circuit Judges.


Sigmapharm Laboratories, LLC, ("Sigmapharm"), Hikma Pharmaceuticals LLC, Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc., (collectively, "Hikma"), Breckenridge Pharmaceuticals Inc. ("Breckenridge"), Alembic Pharmaceuticals Ltd., Alembic Global Holdings S.A., Alembic Pharmaceuticals Inc., (collectively,

NEVER MISS A DECISION. START YOUR SUBSCRIPTION.

Uncompromising quality. Enduring impact.
Your support ensures a bright future for independent legal reporting.

As you are aware we have offered this as a free subscription over the past years and we have now made it a paid service.Look forward to your continued patronage.

GET STARTED


OR

Read it with your Leagle account.
Sign in to continue


Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases